Answers are grounded in this paper and cite their sources.
Background Long-term cause-specific neurological mortality trends in Ecuador remain insufficiently characterized. This study examined mortality trends from 1997 to 2024 and quantified the contributions of demographic change and age-specific mortality rates to changes in annual deaths. Methods We conducted a nationwide time-series study using national mortality and population data for 1997–2024. Six neurological conditions were examined: cerebrovascular disease, dementia/Alzheimer disease, Parkinson disease, epilepsy/status epilepticus, meningitis, and malignant brain neoplasm. Crude and World Health Organization age-standardized mortality rates were calculated. Temporal trends were assessed using weighted segmented log-linear regression with overdispersion-adjusted inference and bootstrap assessment of breakpoint stability. Changes in annual deaths were decomposed into population growth, age structure, and age-specific mortality-rate effects using a Shapley approach. Results Cerebrovascular deaths increased from 2,280 to 4,836, although age-standardized mortality declined by 16.5% (average annual percentage change, − 0.85%; 95% confidence interval, − 1.29 to − 0.40). Dementia/Alzheimer mortality increased markedly (average annual percentage change, + 7.73%), with changes in age-specific mortality accounting for the largest share of the increase in deaths. Parkinson mortality also increased (+ 2.50% annually), whereas epilepsy (− 1.33%) and meningitis (− 3.12%) declined. For cerebrovascular disease, declining age-specific mortality partly offset strong contributions from population growth and population aging. Sensitivity analyses using three-year endpoints and the pre-pandemic period preserved the main directions. Conclusions Neurological mortality in Ecuador underwent a heterogeneous transition. Disease-specific planning should distinguish changes in absolute mortality burden from changes in age-standardized recorded mortality. Clinical trial registration Clinical trial number: not applicable. This study was a retrospective analysis of publicly available national mortality and population data and did not involve any clinical intervention or prospective assignment of participants.
No takes yet. Share an insight, caveat, or question.
Muñoz-Gualán et al. (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: